Chunghwa Chemical Synthesis & Biotech Co., Ltd. (TPE:1762)

TPE:1762 Revenue

Chunghwa Chemical Synthesis & Biotech had revenue of 305.18M TWD in the quarter ending June 30, 2026, a decrease of -11.29%. This brings the company's total for the last twelve months to 934.29M, down -20.25% year-over-year. In the year 2025, Chunghwa Chemical Synthesis & Biotech had annual revenue of 804.88M, down -40.26%. That makes Chunghwa Chemical Synthesis & Biotech the 31,599th largest company in the world by revenue and 1,608th in Taiwan.

• Revenue (ttm): 934.29M
• Revenue Growth: -20.25%
• P/S Ratio: 2.83
• Revenue / Employee: 4.72M
• Employees: 198
• Market Cap: 2.65B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Taiwan Region 782.85M 71.1%
• US Region 318.06M 28.9%

By Geography

Chart

• United States 323.57M 40.2%
• Japan 106.06M 13.2%
• Greece 105.78M 13.1%
• Croatia 80.58M 10.0%
• Others 72.97M 9.1%
• Taiwan 66.69M 8.3%
• India 49.23M 6.1%

Fiscal year ended Dec 31, 2025 See the full TPE:1762 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	804.88M	-542.50M	-40.26%
Dec 31, 2024	1.35B	-739.07M	-35.42%
Dec 31, 2023	2.09B	-30.70M	-1.45%
Dec 31, 2022	2.12B	182.44M	9.43%
Dec 31, 2021	1.93B	391.11M	25.34%

Data Source: S&P Global Market Intelligence Last updated: Aug 12, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 17, 2026

Data Sources Report a data error